Access links:
CONTENT
Destacados
-
Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients.
Laguno, M., Larrousse, M., Blanco, J. L., Leon, A., Milinkovic, A., Martinez-Rebozler, M., Lonca, M., Martinez, E., Sanchez-Tapias, J. M., de Lazzari, E., et al.AIDS Res Hum Retroviruses 24, 547-553. F: 2,022, Q: 2nd. Virology
-
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.
Opravil M, Sasadeusz J, Cooper DA, Rockstroh JK, Clumeck N, Clotet B, Montaner J, Torriani FJ, Depamphilis J, Dieterich DT.J Acquir Immune Defic Syndr. 47:36-49
-
Towards novel S-DABOC inhibitors: Synthesis, biological investigation, and molecular modeling studies.
Radi, M., Angeli, L., Franchi, L., Contemori, L., Maga, G., Samuele, A., Zanoli, S., Armand-Ugon, M., Gonzalez, E., Llano, A., et al.Bioorg Med Chem Lett.
-
HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro
Moncunill, G., Armand-Ugon, M., Pauls, E., Clotet, B., and Este, J. A.Aids 22, 23-31
-
Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.
Sirera, G., Videla, S., Lopez-Blazquez, R., Llatjos, M., Tarrats, A., Castella, E., Grane, N., Tural, C., Rey-Joly, C., and Clotet, B.J Antimicrob Chemother 61, 191-194. IF: 4,038, Q: 21st. Pharmacology
